JP Morgan Chase’s Hinge Health HNGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$29.6M Buy
804,431
+13,516
+2% +$562K ﹤0.01% 1751
2025
Q4
$36.7M Buy
790,915
+46,859
+6% +$2.26M ﹤0.01% 1573
2025
Q3
$36.5M Sell
744,056
-103,089
-12% -$5.39M ﹤0.01% 1624
2025
Q2
$43.8M Buy
+847,145
New +$34.2M ﹤0.01% 1407

Other funds holding HNGE

JP Morgan Chase's HNGE Position: Q1 2026 in Review

JP Morgan Chase increased its Hinge Health (HNGE) stake by 1.7% in Q1 2026, buying an estimated $562K and bringing the position to 804,431 shares worth $29.6M. The position accounts for ﹤0.01% of the portfolio, ranked #1751.

JP Morgan Chase first reported a position in HNGE in Q2 2025 and has held it in 4 quarters since. The position peaked at $43.8M in Q2 2025. 203 funds tracked by Wall St. Rank hold HNGE as of Q1 2026.

  • JP Morgan Chase held 804,431 shares of Hinge Health worth $29.6M as of Q1 2026.
  • JP Morgan Chase bought 13,516 Hinge Health shares in Q1 2026, an estimated $562K.
  • Hinge Health made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1751 holding.
  • JP Morgan Chase first reported a position in Hinge Health in Q2 2025 and has held it in 4 quarters since.
  • JP Morgan Chase's Hinge Health position peaked at $43.8M in Q2 2025.
  • 203 funds tracked by Wall St. Rank held Hinge Health as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.